One biopharma professional doesn’t think so, another thinks very much, and a third has her own idea of a “hybrid” management model. An intriguing dialogue you will want to hear firsthand.
Interested in the complete presentation? Click here.
Get the latest articles from Outsourced Pharma delivered to your inbox.